May 2022 - Page 2 of 3

New Gold Completes Redemption Of Its Remaining Outstanding 6.375% Senior Notes

PR Newswire TORONTO , May 16, 2022 /PRNewswire/ – New Gold Inc. (“New Gold” or the “Company”) (TSX: NGD) (NYSE American: NGD) announces completion of the previously announced redemption of its outstanding $100 million aggregate ... [Read]

Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases

May 15

PR Newswire SAN DIEGO and SHANGHAI , May 15, 2022 /PRNewswire/ — Inmagene Biopharmaceuticals (“Inmagene”) announces that today the U.S. Food and Drug Administration (FDA) cleared its investigational new drug (IND) application for the drug ... [Read]

Calliditas Therapeutics Launches an Online Patient Platform

May 14

This launch coincides with the inaugural IgAN Awareness Day STOCKHOLM, Sweden, May 14, 2022 (GLOBE NEWSWIRE) — Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced the launch of IgAN Connect, a new ... [Read]

Stock Market Today: Dow Jones, S&P 500 Pushes Higher; Affirm Stock Surges On Solid Earnings & Partnership With Shopify

May 13

Stock Market Today Mid-Morning Updates On Friday, the Dow Jones Industrial Average is up by 380 points despite concerns over persistent inflation and worries on whether the Federal Reserve can get inflation under control. Fed ... [Read]

Signal Gold (Formerly Anaconda Mining) Announces Results from Annual and Special Meeting of Shareholders

May 12

TORONTO, ON / ACCESSWIRE / May 12, 2022 / Signal Gold Inc., previously Anaconda Mining Inc., (“Signal Gold” or the “Company”) (TSX:ANX) (OTCQX:ANXGF) is pleased to announce that it has changed its name to Signal ... [Read]

Fortuna Reports Net Income of $27.0 million in the First Quarter of 2022

May 11

(All amounts expressed in US dollars, tabular amounts in millions, unless otherwise stated) VANCOUVER, British Columbia, May 11, 2022 (GLOBE NEWSWIRE) — Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) (“Fortuna” or the “Company”) today ... [Read]

Aileron Therapeutics Announces Late-Breaking Oral Presentation of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles and Their Stem Cells from Chemotherapy-Induced Damage at Upcoming Society for Investigative Dermatology 2022 Annual Meeting

May 10

Taxanes, such as paclitaxel and docetaxel, cause severe and often permanent chemotherapy-induced hair loss (alopecia) New non-clinical data demonstrate proof of principle that ALRN-6924 can temporarily arrest the cell cycle in human scalp hair follicles ... [Read]

Month: May 2022